These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 16847062)

  • 21. New insights into the classical and non-classical actions of estrogen: evidence from estrogen receptor knock-out and knock-in mice.
    McDevitt MA; Glidewell-Kenney C; Jimenez MA; Ahearn PC; Weiss J; Jameson JL; Levine JE
    Mol Cell Endocrinol; 2008 Aug; 290(1-2):24-30. PubMed ID: 18534740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of estrogen receptor transactivation and estrogen-induced gene expression by ormeloxifene-a triphenylethylene derivative.
    Blesson CS; Awasthi S; Kharkwal G; Daverey A; Dwivedi A
    Steroids; 2006 Nov; 71(11-12):993-1000. PubMed ID: 16965798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.
    Son J; Park JW; Lambert PF; Chung SH
    Carcinogenesis; 2014 Feb; 35(2):489-96. PubMed ID: 24148821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterine epithelial estrogen receptor α is dispensable for proliferation but essential for complete biological and biochemical responses.
    Winuthayanon W; Hewitt SC; Orvis GD; Behringer RR; Korach KS
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19272-7. PubMed ID: 20974921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear receptor co-regulator Krüppel-like factor 9 and prohibitin 2 expression in estrogen-induced epithelial cell proliferation in the mouse uterus.
    Pabona JM; Velarde MC; Zeng Z; Simmen FA; Simmen RC
    J Endocrinol; 2009 Jan; 200(1):63-73. PubMed ID: 18835980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen.
    Kurita T; Medina R; Schabel AB; Young P; Gama P; Parekh TV; Brody J; Cunha GR; Osteen KG; Bruner-Tran KL; Gold LI
    Differentiation; 2005 Jul; 73(6):313-22. PubMed ID: 16138832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen responses in bovine fetal uterine cells involve pathways directed by both estrogen response element and activator protein-1.
    Malayer JR; Cheng J; Woods VM
    Biol Reprod; 1999 May; 60(5):1204-10. PubMed ID: 10208985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural estrogenic compound diarylheptanoid (D3): in vitro mechanisms of action and in vivo uterine responses via estrogen receptor α.
    Winuthayanon W; Piyachaturawat P; Suksamrarn A; Burns KA; Arao Y; Hewitt SC; Pedersen LC; Korach KS
    Environ Health Perspect; 2013 Apr; 121(4):433-9. PubMed ID: 23552522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
    Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
    Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription.
    Qi X; Zhi H; Lepp A; Wang P; Huang J; Basir Z; Chitambar CR; Myers CR; Chen G
    J Biol Chem; 2012 Apr; 287(18):14681-91. PubMed ID: 22399296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.
    Mao C; Patterson NM; Cherian MT; Aninye IO; Zhang C; Montoya JB; Cheng J; Putt KS; Hergenrother PJ; Wilson EM; Nardulli AM; Nordeen SK; Shapiro DJ
    J Biol Chem; 2008 May; 283(19):12819-30. PubMed ID: 18337247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine epithelial cell estrogen receptor alpha-dependent and -independent genomic profiles that underlie estrogen responses in mice.
    Winuthayanon W; Hewitt SC; Korach KS
    Biol Reprod; 2014 Nov; 91(5):110. PubMed ID: 25210133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation.
    Chen B; Pollard JW
    Mol Endocrinol; 2003 Jul; 17(7):1368-81. PubMed ID: 12649329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.
    Klotz DM; Hewitt SC; Ciana P; Raviscioni M; Lindzey JK; Foley J; Maggi A; DiAugustine RP; Korach KS
    J Biol Chem; 2002 Mar; 277(10):8531-7. PubMed ID: 11751931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of loss of classical estrogen response element signaling on bone in male mice.
    Syed FA; Fraser DG; Spelsberg TC; Rosen CJ; Krust A; Chambon P; Jameson JL; Khosla S
    Endocrinology; 2007 Apr; 148(4):1902-10. PubMed ID: 17204553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
    Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
    Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
    Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
    Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
    Liu J; Li J; Sidell N
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
    Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.